Hypofractionated Stereotactic Body Radiation Therapy as Monotherapy for Intermediate-Risk Prostate Cancer
Radiation Oncology - United Kingdom
doi 10.1186/1748-717x-8-30
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC